Keeping Current CME artwork

Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Context and Impact of New Data

Keeping Current CME

English - April 05, 2022 18:00 - 33 minutes - 31.9 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers
Next Episode: A Critical Review of Learnings From the ’21 Clinical Trials on Alzheimer's Disease Conference

Did you know that noncovalent BTK inhibitors are potentially the answer to the development of resistance to covalent BTK inhibitors?

Credit available for this activity expires: 4/5/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/971263?src=mkm_podcast_addon_971263